CE for this activity will not be available after this date.
Conference Level: CompetentOverview Hypertension, in particular isolated systolic hypertension, is a common problem in adults aged 65 and older, reaching a prevalence of 70%. Hypertension is a leading cause of preventable mortality, and a major contributor of premature disability and institutionalization. The treatment of HTN in older adults is complicated by a high comorbidity burden, polypharmacy and frailty. Despite these challenges, blood pressure reduction has shown to lower the risk of cardiovascular events and death in older adults. Compared to moderate BP reduction, intensive BP lowering is associated with incrementally greater benefits in some patients but also elevates the risk of side effects, especially orthostatic hypotension. The attained BP reduction, and not the particular drug class, is the primary determinant of treatment outcomes. Decisions regarding intensity of BP lowering and choice of antihypertensive medications should be made from the life-course perspective, considering patient comorbidities, functional status and quality of life of older adults.
This CE activity is a recording of a CE session from the AANP 2019 National Conference. It has been edited to meet requirements for online learning.If you received CE credit for attending the live session at Conference, you many not receive duplication credit for this same activity in a different format.CE Credit Instructions Read this activity description, including objectives and disclosures. Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the posttest
Submit the evaluation to receive full AANP CE/Rx credit.
Review current evidence related to HTN treatment in older adults
Discuss best practices for integrating evidence into patient care
Apply knowledge to hypothetical cases
Speaker Molly Bradshaw, DNP, APRN, FNP-BC, WHNP-BC Disclosure This program was planned in accordance with AANP CE Standards and Policies. Dr. Bradshaw has no relevant affiliations to disclose.
Financially supported by the Transforming Clinical Practice Initiative (TCPi) grant, a Center for Medicare & Medicaid Services (CMS) award that provides free continuing education on topics related to patient & family-centered care, data-driven quality improvement and sustainable business operations.
This educational activity may contain opinions of the authors from their personal experience. The activity may contain discussion of published and/ or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/ participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, 0.5 of which may be applied towards Pharmacology
Additional CE activities of interest
(OnDemand) Understanding Asthma-COPD Overlap
(OnDemand) Antimicrobial Therapy: Best Practice
(OnDemand) Venous Thromboembolism: Current Recommendations for Evaluating and Management in the Primary Care Setting
(OnDemand) Managing Heart Failure: Clinical Pearls for Nurse Practitioners 2018
(OnDemand) Hypertension: How Low Should You Go?
(OnDemand) The Essentials: Managing Hypertension in Primary Care
(OnDemand) Marijuana: It's Approved, Now What?
(OnDemand) Neurological Emergencies for the Generalist Nurse Practitioner
(OnDemand) 12 Lead ECG Interpretation
(OnDemand) 2019 Contraceptive Update
(OnDemand) Hypoglycemia: Advanced Management in the Adult Patient